Marsha Wittink, M.D., studies how to empower older patients. Learn more Rudi Fasan, Ph.D., Ben Frisch, Ph.D., and Danielle Benoit, Ph.D. are collaborating to develop a new leukemia drug and a new way of delivering it with nanoparticles. Learn more Laura Calvi, M.D. and Jacky Williams, Ph.D., are studying the tumor microenvironment using a new high-technology device that will allow them to look more deeply into connections between cancer cells and surrounding tissues. Learn more Melvin King, research assistant, works with Brad Smith, Ph.D., and Josh Munger, Ph.D., who are collaborating to study how cancer cells reproduce. Learn more
Research News Cancer Immunotherapy: Researchers Earn NIH Grant to Improve T-Cell AttackScientists Move Closer Toward Ovarian Cancer Detection, DiagnosisWilmot Physician Receives National Leadership Award in Cancer and AgingNCI Awards $2M to Wilmot Team for Pancreatic Cancer Research Prostate Cancer Researchers Find Molecular “Switch” to Prolong Survival
Research Programs The Wilmot Cancer Institute has a large, dedicated group of scientists from 30 academic departments at the University of Rochester and the Wilmot Cancer Institute. Thanks to ongoing basic and clinical research by our teams, patients throughout upstate New York continuously gain new survival advantages. Hallmarks of Cancer Tumor Microenvironment Cancer Control & Survivorship